Susquehanna International Group
INFI

Susquehanna International Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Susquehanna International Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,008
Closed -$2.32K – 13370
2023
Q2 		$2.32K Sell
11,008
-97,740
-90% -$17K ﹤0.01% 11861
2023
Q1 		$17.4K Buy
108,748
+14,184
+15% +$6.3K ﹤0.01% 12079
2022
Q4 		$52.5K Buy
94,564
+64,543
+215% +$54.9K ﹤0.01% 11368
2022
Q3 		$36K Sell
30,021
-126,530
-81% -$136K ﹤0.01% 12387
2022
Q2 		$99K Buy
156,551
+111,498
+247% +$85.6K ﹤0.01% 11493
2022
Q1 		$51K Sell
45,053
-150,026
-77% -$179K ﹤0.01% 12308
2021
Q4 		$439K Buy
195,079
+73,116
+60% +$184K ﹤0.01% 9529
2021
Q3 		$417K Sell
121,963
-73,949
-38% -$228K ﹤0.01% 9842
2021
Q2 		$586K Sell
195,912
-515,726
-72% -$1.63M ﹤0.01% 9216
2021
Q1 		$2.3M Buy
711,638
+667,072
+1,497% +$2.23M ﹤0.01% 5588
2020
Q4 		$94K Buy
44,566
+10,222
+30% +$16.9K ﹤0.01% 10524
2020
Q3 		$40K Sell
34,344
-853
-2% -$876 ﹤0.01% 10260
2020
Q2 		$32K Buy
35,197
+15,756
+81% +$15K ﹤0.01% 9859
2020
Q1 		$16K Sell
19,441
-13,187
-40% -$15.3K ﹤0.01% 9983
2019
Q4 		$31K Buy
32,628
+21,928
+205% +$24.1K ﹤0.01% 9435
2019
Q3 		$11K Buy
+10,700
New +$14.6K ﹤0.01% 10013
2019
Q2 		– Sell
-80,328
Closed -$129K – 11017
2019
Q1 		$151K Buy
+80,328
New +$118K ﹤0.01% 8046
2018
Q4 		– Sell
-63,952
Closed -$115K – 10231
2018
Q3 		$173K Sell
63,952
-15,550
-20% -$32.2K ﹤0.01% 8330
2018
Q2 		$152K Sell
79,502
-165,239
-68% -$334K ﹤0.01% 8828
2018
Q1 		$514K Buy
244,741
+95,880
+64% +$206K ﹤0.01% 6578
2017
Q4 		$302K Buy
+148,861
New +$309K ﹤0.01% 7586
2017
Q3 		– Sell
-109,574
Closed -$172K – 9842
2017
Q2 		$172K Buy
+109,574
New +$211K ﹤0.01% 8418
2017
Q1 		– Sell
-93,061
Closed -$229K – 10243
2016
Q4 		$126K Buy
+93,061
New +$122K ﹤0.01% 8965
2016
Q2 		– Sell
-13,816
Closed -$64.6K – 9516
2016
Q1 		$73K Sell
13,816
-95,991
-87% -$587K ﹤0.01% 8552
2015
Q4 		$862K Sell
109,807
-21,430
-16% -$184K ﹤0.01% 5714
2015
Q3 		$1.11M Buy
131,237
+47,910
+57% +$442K ﹤0.01% 5522
2015
Q2 		$912K Buy
83,327
+24,566
+42% +$315K ﹤0.01% 6412
2015
Q1 		$821K Sell
58,761
-166,777
-74% -$2.55M ﹤0.01% 6149
2014
Q4 		$3.81M Sell
225,538
-121,827
-35% -$1.77M ﹤0.01% 3300
2014
Q3 		$4.66M Buy
347,365
+140,228
+68% +$1.67M ﹤0.01% 3126
2014
Q2 		$2.64M Buy
207,137
+30,904
+18% +$322K ﹤0.01% 4131
2014
Q1 		$2.1M Sell
176,233
-368,611
-68% -$4.95M ﹤0.01% 4266
2013
Q4 		$7.53M Buy
544,844
+442,837
+434% +$6.25M ﹤0.01% 2398
2013
Q3 		$1.78M Sell
102,007
-151,481
-60% -$2.9M ﹤0.01% 4295
2013
Q2 		$4.12M Buy
+253,488
New +$7.84M ﹤0.01% 2871

Other funds holding INFI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Susquehanna International Group's INFI Position: Q3 2023 in Review

Susquehanna International Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 11,008 shares — an estimated $2.32K sold.

Susquehanna International Group first reported a position in INFI in Q2 2013 and held it in 35 quarters. The position peaked at $7.53M in Q4 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Susquehanna International Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 11,008 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $2.32K.
  • Susquehanna International Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 35 quarters.
  • Susquehanna International Group's Infinity Pharmaceuticals, Inc. position peaked at $7.53M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.